Flecainide augments muscle sympathetic nerve activity in humans

Circulation Journal

Volumn 66, Issue 4, 2002, Pages 377-381

  Nagata, Yoshiki ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

Flecainide acetate; Muscle sympathetic nerve activity; Negative inotropic action; Propranolol hydrochloride

Indexed keywords

FLECAINIDE ACETATE; PROPRANOLOL;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DYE DILUTION CURVE; FEMALE; HEART ARRHYTHMIA; HEART INDEX; HEART OUTPUT; HEART RATE; HEMODYNAMIC MONITORING; HUMAN; INCIDENCE; INOTROPISM; JAPAN; MALE; MUSCLE CONTRACTION; MUSCLE INNERVATION; NEUROGRAPHY; SYMPATHETIC INNERVATION; SYMPATHETIC NERVE;

ADULT; ANTI-ARRHYTHMIA AGENTS; BLOOD PRESSURE; DIASTOLE; ELECTROCARDIOGRAPHY; FEMALE; FLECAINIDE; HEART RATE; HUMANS; MALE; MIDDLE AGED; PROPRANOLOL; REFERENCE VALUES; SYMPATHETIC NERVOUS SYSTEM; SYSTOLE; VASCULAR RESISTANCE;

EID: 0036238749     PISSN: 13469843     EISSN: None     Source Type: Journal    
DOI: 10.1253/circj.66.377     Document Type: Article

References (37)

1. Mortality and morbidity in patients receiving encainide, flecainide, or placebo
2. Interaction of baseline characteristics with the hazard of encainide, flecainide, and moricizine therapy in patients with myocardial infarction: A possible explanation for increased mortality in the Cardiac Arrhythmia Suppression Trial (CAST)
3. Circadian pattern of arrhythmic death in patients receiving encainide, flecainide or moricizine in the cardiac arrhythmia suppression trial (CAST)
4. Beta-blocker therapy in the cardiac arrhythmia suppression trial
5. β-adrenergic augmentation of flecainide-induced conduction slowing in canine Purkinje fibers
6. Comparative study on the proarrhythmic effects of some antiarrhythmic agents
7. Malignant arrhythmias and acute myocardial ischemia: Interaction between flecainide and the autonomic nervous system
8. Reversal of proarrhythmic effects of flecainide acetate and encainide hydrochloride by propranolol
9. Inhibitory effects of procainamide on sympathetic nerve activity in humans
10. Effects of quinidine on vascular resistance and sympathetic nerve activity in humans
11. Heart rate variability in patients with ventricular arrhythmias: Effect of antiarrhythmic drugs
12. Autonomic effects of antiarrhythmic drugs and their importance
13. Hemodynamic effects of intravenous flecainide relative to the level of ventricular function in patients with coronary artery disease
14. Hemodynamic effects of flecainide in relation to its serum concentration
15. Pulse and respiratory grouping of sympathetic impulses in human muscle nerves
16. General characteristics of sympathetic activity in human muscle nerves
17. Acute changes in the properties of baroreflexes in man after β-blockade
18. Plasma concentrations and the time-course of beta blockade due to propranolol
19. Role of neurohormonal mechanisms in determining survival in patients with severe chronic heart failure
20. Circadian variation in the frequency of onset of acute myocardial infarction
21. Sympathetic hyperactivity and coronary risk in hypertension
22. Sudden cardiac death
23. Circadian variation of autonomic nervous activity in patients with multivessel coronary spasm
24. Calcium channel blockers in acutemyocardial infarction and unstable angina: An overview
25. Differential activation of cardiac and peripheral sympathetic nervous system by nifedipine: Role of pharmacokinetics
26. Influence of lidocaine on human muscle sympathetic nerve activity during programmed electrical stimulation and ventricular tachycardia
27. Characteristics of left ventricular receptors with non-medullated vagal afferents in cats
28. Effect of d- and I-propranolol on discharge of cardiac vagal C fibers
29. Contrasting effects of propranolol on sympathetic nerve activity and vascular resistance during orthostatic stress
30. Spectral analysis of heart rate, arterial pressure, and muscle sympathetic nerve activity in normal humans
31. Characterization of a new oral antiarrhythmic drug, flecainide
32. Simultaneous measurements of cardiac noradrenaline spillover and sympathetic outflow to skeletal muscle in humans
33. Circadian variation in the frequency of sudden cardiac death
34. Circadian variation in the incidence of sudden cardiac death in the Framingham Heart Study population
35. Circadian variation of ambulatory myocardial ischemia: Triggering by daily activities and evidence for an endogenous circadian compounent
36. Circadian variation in human ventricular refractoriness
37. Arrhythmias in patients with Brugada-type electrocardiographic findings